Giant Retroperitoneal Dedifferentiated Liposarcoma

Öz

Retroperitoneal sarcoma is derived from connective tissue, fat and muscle tissues, and mesodermal stem cells and makes up of 0.1-0.2% of all malignant tumors and 15% of all sarcomas. Liposarcoma is the most common type and is followed by leiomyosarcoma, malignant fibrous histiocytoma, fibrosarcoma and other undifferentiated sarcomas. A 53-year-old man presented to our clinic with persisting complaints of pain and abdominal distention. A mass was detected at the retroperitoneal region after radiological examination and the patient was taken to surgery. During the operation, the mass was totally excised with the left kidney. The mass was sent for pathological examination and was reported as dedifferentiated liposarcoma. In this report, a rare case of retroperitoneal liposarcoma is presented

Anahtar Kelimeler

• Retroperitoneal, Sarcoma, Dedifferentiated

Dev Retroperitoneal Dedifferansiye Liposarkom

Öz

Retroperitoneal sarkomlar; bağ doku, yağ ve kas dokunun mesodermik kök hücrelerinden köken alır ve tüm malign tümörlerin %0,1-%0,2 sini, tüm sarkomların %15 ini oluşturur. Liposarkom en sık görülen tiptir ve bunu leiomyosarkom, malign fibröz histiyositom, fibrosarkom ve diğer undifferensiye sarkomlar takip eder. Kliniğimize sebat eden karın ağrısı ve abdominal distansiyon şikayetleriyle başvuran 53 yaşında erkek hastada yapılan tetkikler neticesinde retroperitoneal bölgede kitle tespit edilmiş ve hasta ameliyata alınmıştır. Ameliyatta, kitle sol böbrek ile beraber eksize edilmiş ve patoloji sonucu dedifferansiye liposarkom olarak raporlanmıştır. Yazıda nadir görülen bir retroperitoneal liposarkom olgusu sunuldu

Anahtar Kelimeler

• Retroperitoneal, Sarkom, Dediferansiye

Kaynakça

1. Neuhaus SJ, Barry P, Clark MA, Hayes AJ, Fisher C, Thomas JM. Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg 2005;92(2):246-52.
2. Porter G, Baxter N, Pisters P. Retroperitoneal Sarcoma: A population-based analysis of epidemiology, surgery, and radiotherapy. Cancer 2006;106(7):1610-6.
3. Crago AM, Singer S. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma. Curr Opin Oncol 2011;23(4):373-8.
4. Shibata D, Lewis JJ, Leung DH, Brennan MF. Is there a role for incomplete resection in the management of retroperitoneal liposarcomas? J Am Coll Surg 2001;193(4):373-9.
5. Swallow CJ, Catton CN. Improving outcomes for retroperitoneal sarcomas: A work in progress. Surg Oncol Clin N Am 2012;21(2): 317-31.
6. Dalal KM, Kattan MW, Antonescu CR, Brennan MF, Singer S. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg 2006;244(3):381-91.
7. Fletcher C, Unni K, Mertens FE. World Health Organization classification of tumors. Pathology and genetics of tumours of soft tissue and bone. Lyon: IACR Press;2002.
8. Lucas DR, Nascimento AG, Sanjay BK, Rock MG. Well- differentiated liposarcoma. The Mayo Clinic experience with 58 cases. Am J Clin Pathol 1994;102(5):677-83.

9. Wu MJ, Montgomery E. Classification and pathology. Surg Clin N Am 2008:88(3); 483-520.
10. Lahat G, Lazar A, Lev D. Sarcoma epidemiology and etiology: Potential environmental and genetics factors. Surg Clin N Am 2008:88(3); 451-81.
11. Tzeng CD, Smith JK, Heslin MJ. Soft tissue sarcoma: Preoperative and postoperative imaging for staging. Surg Oncol Clin N Am 2007:16(2); 389-402.
12. Clark MA, Fisher C, Judson IJ, Thomas JM. Soft tissue sarcomas in adults. N Engl J Med 2005;353:701-11.
13. Kaushal A, Citrin D. The role of radiation therapy in the management of sarcomas. Surg Clin N Am 2008:88(3); 629-46.
14. Thornton K. Chemotherapeutic management of soft tissue sarcoma. Surg Clin N Am 2008:88(3); 647-60.